M
Meagan B. Myers Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Research Biologist
faculty
19 h-index
48 pubs
939 cited
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Meagan B. Myers' research focuses on genotoxicity and cancer risk assessment, particularly utilizing advanced sequencing technologies. Her work investigates the detection and quantification of mutations in animal models to understand their role in carcinogenesis. Recent publications highlight the application of error-corrected next-generation sequencing, such as duplex sequencing, for improving the accuracy of genotoxicity testing and assessing cancer driver mutations in rodent models.
Myers also contributes to the development of consensus recommendations for evaluating the safety of cell therapy products, specifically addressing teratoma formation risk. Her research network includes several collaborators from the National Center for Toxicological Research, with whom she has co-authored multiple publications. Her scholarship metrics include an h-index of 19 and a total of 49 publications with 910 citations.
Metrics
- h-index: 19
- Publications: 48
- Citations: 939
Selected Publications
-
Using error-corrected sequencing for evaluating mutagenicity of molnupiravir in humans (2026)
-
Transferability, Reproducibility and Sensitivity of Mutation Quantification by Duplex Sequencing (2025)
-
Evaluating teratoma formation risk of pluripotent stem cell-derived cell therapy products: a consensus recommendation from the Health and Environmental Sciences Institute’s International Cell Therapy Committee (2025)
-
CarcSeq detection of lorcaserin-induced clonal expansion of<i>Pik3ca</i>H1047R mutants in rat mammary tissue (2024)
-
<scp>Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing</scp> (<scp>IWGT</scp>) (2024)
-
Error-corrected next generation sequencing – Promises and challenges for genotoxicity and cancer risk assessment (2023)
-
A Brief Practical Guide to PCR (2023)
-
Clinical Applications of Nucleic Acid Amplification (2023)
-
Error-corrected next-generation sequencing to advance nonclinical genotoxicity and carcinogenicity testing (2023)
-
Assessment of Clonal Expansion Using CarcSeq Measurement of Lung Cancer Driver Mutations and Correlation With Mouse Strain- and Sex-Related Incidence of Spontaneous Lung Neoplasia (2021)
Collaboration Network
Top Collaborators
Barbara L. Parsons
United States Food and Drug Administration
7 shared publications
In database
- Error-corrected next generation sequencing – Promises and challenges for genotoxicity and cancer risk assessment
- Error-corrected next-generation sequencing to advance nonclinical genotoxicity and carcinogenicity testing
- CarcSeq Measurement of Rat Mammary Cancer Driver Mutations and Relation to Spontaneous Mammary Neoplasia
- Assessment of Clonal Expansion Using CarcSeq Measurement of Lung Cancer Driver Mutations and Correlation With Mouse Strain- and Sex-Related Incidence of Spontaneous Lung Neoplasia
- <scp>Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing</scp> (<scp>IWGT</scp>)
Showing 5 of 7 shared publications
Connie L. Chen
Health and Environmental Sciences Institute (US)
4 shared publications
- Error-corrected next generation sequencing – Promises and challenges for genotoxicity and cancer risk assessment
- Error-corrected next-generation sequencing to advance nonclinical genotoxicity and carcinogenicity testing
- Evaluating teratoma formation risk of pluripotent stem cell-derived cell therapy products: a consensus recommendation from the Health and Environmental Sciences Institute’s International Cell Therapy Committee
- Transferability, Reproducibility and Sensitivity of Mutation Quantification by Duplex Sequencing
Francesco Marchetti
Health Canada (CA)
3 shared publications
- Error-corrected next generation sequencing – Promises and challenges for genotoxicity and cancer risk assessment
- Error-corrected next-generation sequencing to advance nonclinical genotoxicity and carcinogenicity testing
- Transferability, Reproducibility and Sensitivity of Mutation Quantification by Duplex Sequencing
George R. Douglas
Health Canada (CA)
3 shared publications
- Error-corrected next generation sequencing – Promises and challenges for genotoxicity and cancer risk assessment
- Error-corrected next-generation sequencing to advance nonclinical genotoxicity and carcinogenicity testing
- <scp>Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing</scp> (<scp>IWGT</scp>)
Robert H. Heflich
National Center for Toxicological Research
3 shared publications
In database
- Error-corrected next generation sequencing – Promises and challenges for genotoxicity and cancer risk assessment
- Error-corrected next-generation sequencing to advance nonclinical genotoxicity and carcinogenicity testing
- <scp>Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing</scp> (<scp>IWGT</scp>)
Anthony M. Lynch
Genetic Technologies (Australia) (AU)
3 shared publications
- Error-corrected next generation sequencing – Promises and challenges for genotoxicity and cancer risk assessment
- Error-corrected next-generation sequencing to advance nonclinical genotoxicity and carcinogenicity testing
- <scp>Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing</scp> (<scp>IWGT</scp>)
Jesse J. Salk
Blaze Bioscience (United States) (US)
3 shared publications
- Error-corrected next generation sequencing – Promises and challenges for genotoxicity and cancer risk assessment
- Error-corrected next-generation sequencing to advance nonclinical genotoxicity and carcinogenicity testing
- Transferability, Reproducibility and Sensitivity of Mutation Quantification by Duplex Sequencing
Raja S. Settivari
Corteva (United States) (US)
3 shared publications
- Error-corrected next generation sequencing – Promises and challenges for genotoxicity and cancer risk assessment
- Error-corrected next-generation sequencing to advance nonclinical genotoxicity and carcinogenicity testing
- Transferability, Reproducibility and Sensitivity of Mutation Quantification by Duplex Sequencing
Stephanie L. Smith‐Roe
Triangle (US)
3 shared publications
- Error-corrected next generation sequencing – Promises and challenges for genotoxicity and cancer risk assessment
- Error-corrected next-generation sequencing to advance nonclinical genotoxicity and carcinogenicity testing
- Transferability, Reproducibility and Sensitivity of Mutation Quantification by Duplex Sequencing
Carole L. Yauk
University of Ottawa (CA)
3 shared publications
- Error-corrected next generation sequencing – Promises and challenges for genotoxicity and cancer risk assessment
- Error-corrected next-generation sequencing to advance nonclinical genotoxicity and carcinogenicity testing
- Transferability, Reproducibility and Sensitivity of Mutation Quantification by Duplex Sequencing
Karen L. McKim
National Center for Toxicological Research
2 shared publications
In database
- CarcSeq Measurement of Rat Mammary Cancer Driver Mutations and Relation to Spontaneous Mammary Neoplasia
- Assessment of Clonal Expansion Using CarcSeq Measurement of Lung Cancer Driver Mutations and Correlation With Mouse Strain- and Sex-Related Incidence of Spontaneous Lung Neoplasia
Kelly L. Harris
United States Food and Drug Administration
2 shared publications
In database
- CarcSeq Measurement of Rat Mammary Cancer Driver Mutations and Relation to Spontaneous Mammary Neoplasia
- Assessment of Clonal Expansion Using CarcSeq Measurement of Lung Cancer Driver Mutations and Correlation With Mouse Strain- and Sex-Related Incidence of Spontaneous Lung Neoplasia
Binsheng Gong
United States Food and Drug Administration
2 shared publications
In database
- CarcSeq Measurement of Rat Mammary Cancer Driver Mutations and Relation to Spontaneous Mammary Neoplasia
- Assessment of Clonal Expansion Using CarcSeq Measurement of Lung Cancer Driver Mutations and Correlation With Mouse Strain- and Sex-Related Incidence of Spontaneous Lung Neoplasia
Joshua Xu
National Center for Toxicological Research
2 shared publications
In database
- CarcSeq Measurement of Rat Mammary Cancer Driver Mutations and Relation to Spontaneous Mammary Neoplasia
- Assessment of Clonal Expansion Using CarcSeq Measurement of Lung Cancer Driver Mutations and Correlation With Mouse Strain- and Sex-Related Incidence of Spontaneous Lung Neoplasia
Renato Cardoso
2 shared publications
- Error-corrected next generation sequencing – Promises and challenges for genotoxicity and cancer risk assessment
- Error-corrected next-generation sequencing to advance nonclinical genotoxicity and carcinogenicity testing
Similar Researchers
Based on overlapping research topics
Binsheng Gong
National Center for Toxicological Research
Molecular Biology Techniques and Applications
Cancer-related molecular mechanisms research
Pharmacological Effects and Toxicity Studies
Page B. McKinzie
National Center for Toxicological Research
Carcinogens and Genotoxicity Assessment
Molecular Biology Techniques and Applications
Cancer-related molecular mechanisms research
Karen L. McKim
National Center for Toxicological Research
Carcinogens and Genotoxicity Assessment
Molecular Biology Techniques and Applications
Cancer-related molecular mechanisms research
Robert H. Heflich
National Center for Toxicological Research
Carcinogens and Genotoxicity Assessment
Molecular Biology Techniques and Applications
Cancer-related molecular mechanisms research
Javier R. Revollo
National Center for Toxicological Research
Carcinogens and Genotoxicity Assessment
Molecular Biology Techniques and Applications
Pharmacological Effects and Toxicity Studies
Jaime A. Miranda
National Center for Toxicological Research
Carcinogens and Genotoxicity Assessment
Molecular Biology Techniques and Applications
Pharmacological Effects and Toxicity Studies